Table 4. Safety assessments in participants of β-glucan and placebo groups¹⁾.

¹⁾ Values are means ± SDs.

²⁾ P-values < 0.05 for differences between the β-glucan and placebo groups at baseline were determined by the independent t-test.

₃₎ P-values < 0.05 for differences of changes from baseline between the β-glucan and placebo groups at week 8 were determined by the independent t-test.

RBC, red blood cell; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; SBP, systolic blood pressure; DBP, diastolic blood pressure.